Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Dan Schneider

Tracked across 8 events · 61 articles · First seen May 07, 2026 · Last active Aug 14, 2026

Sentiment
20
Attention
6
Events
8
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 40
Business
Impact: As President and CEO of Cintas, Dan Schneider commented on the company's progress and future opportunities, reflecting leadership's perspective on the company's performance and strategic direction.
Jun 03, 2026 · 6 articles
2 10
Business
Impact: Dan Schneider, CEO of Photocure, commented on the results and strategic progress, highlighting the acquisition of Vesica Health and FDA reclassification as key catalysts.
Jul 29, 2026 · 6 articles
4 60
Business
Impact: Dan Schneider, CEO of FileAI, expressed enthusiasm for the partnership with JRE Ventures, highlighting Japan as a pivotal market and JRE as an ideal partner for demonstrating the capabilities of AI agents in enterprises.
Jun 15, 2026 · 6 articles
3 50
Business
Impact: Dan Schneider, President and CEO of Photocure, highlighted Photocure's expanded vision to develop complementary precision diagnostic solutions and accelerate personalized care.
Jun 08, 2026 · 8 articles
4 0
Regulatory
On August 14, 2026, the U.S. United States — Food and Drug Administration (FDA) published a proposed order in the Federal Register to reclassify cystoscopic systems intended as an aid for the detection of bladder…
Impact: Dan Schneider, CEO of Photocure, publicly welcomed the FDA's proposal, highlighting its importance for the company and the bladder cancer community.
Aug 14, 2026 · 6 articles
6 0
International
Impact: Dan Schneider, from Luther (law firm), commented on Vietnam's IP framework, noting progress in legislation but persistent difficulties in administrative enforcement and online infringement.
May 27, 2026 · 17 articles
2 0
Tech
Photocure ASA announced the publication of a retrospective cohort study in JU Open Plus evaluating the economic implications of blue light cystoscopy (BLC) versus white light cystoscopy (WLC) using Hexvix/Cysview in a real-world setting. The…
Impact: Dan Schneider is the President and CEO of Photocure, mentioned as a contact for the announcement.
Aug 11, 2026 · 6 articles
4 0
Business
May 07, 2026 · 6 articles
Photocure ceo Dan Schneider Dan Schneider is the President and Chief Executive Officer of Photocure, leading
Photocure Dan Schneider
ERGEN INTELLIGENCE
Track Dan Schneider live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.